If you want to know who really controls InMode Ltd. (NASDAQ:INMD), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are institutions ...

InMode Ltd. remains a global leader in minimally invasive aesthetic medical devices, trading at a deep discount with a net cash position covering 58% of market cap. Despite a sharp 85% drawdown since ...

Fintel reports that on December 17, 2025, Canaccord Genuity maintained coverage of InMode (NasdaqGS:INMD) with a Hold recommendation. Analyst Price Forecast Suggests 18.34% Upside As of December 6, ...

Canaccord lowered the firm’s price target on InMode (INMD) to $15 from $16 and keeps a Hold rating on the shares. The firm said they are bullish on the Med-Tech sector heading into 2026 as they expect ...

The latest update is out from InMode ( (INMD)). On November 5, 2025, InMode Ltd. announced its financial results for the third quarter of 2025, reporting revenues of $93.2 million, a decrease from ...

Tap into the wealth of resources you’ll need—getting started is easy Lisa Smith is a writer with a passion for financial journalism, contributing to popular media outlets like Investopedia and ...